PT  - JOURNAL ARTICLE
AU  - Sohn, Albert
AU  - Speier, William
AU  - Lan, Esther
AU  - Aoki, Kymberly
AU  - Fonarow, Gregg C
AU  - Ong, Michael K
AU  - Arnold, Corey W
TI  - Integrating Remote Monitoring into Heart Failure Patients’ Care Regimen: A Pilot Study
AID  - 10.1101/2020.07.16.20155473
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.16.20155473
4099  - http://medrxiv.org/content/early/2020/07/18/2020.07.16.20155473.short
4100  - http://medrxiv.org/content/early/2020/07/18/2020.07.16.20155473.full
AB  - Background Heart failure is a debilitating disease affecting millions of adults in the United States, often leading to hospitalizations and hospital readmissions. Around 50% of readmissions due to heart failure are preventable, with lack of adherence to prescribed self-care as a driving factor. Remote tracking and reminders issued by mobile health devices such as activity trackers and smartphone apps could help to promote self-care, which could potentially reduce these readmissions.Objective This pilot study used minimally-invasive monitoring technologies and patient-reported outcomes to examine the pragmatic feasibility of a remote monitoring regimen.Methods Twenty heart failure patients participated in piloting a remote monitoring regimen. Data collection included: (1) continuous remote monitoring using wrist-worn consumer activity trackers; (2) body weight recording using bathroom scales; (3) dose tracking using smart pill bottles; and (4) patient-reported outcome measures.Results Participants were aged 65.3 years on average, 50.0% of the participants were women, and 81.8% of the participants were determined to be New York Heart Association Class III or higher. Over the course of the study, 60.0% of the subjects wore the activity tracker for at least 70% of the hours, and 45.0% used the bathroom scale for more than 70% of the days. For the smart pill bottle, 55.0% of the subjects used it less than 10% of the days. Usage of the activity tracker correlated significantly with changes in Self-Care of Heart Failure Index confidence subscale scores and changes in Seattle Angina Questionnaire scores (P < .05), and usage of the bathroom scale correlated significantly with changes in Seattle Angina Questionnaire scores (P = .04).Conclusions The majority of the participants maintained a high adherence to wearing the activity tracker, but had low adherence to using the smart pill bottle. Usage of the bathroom scale was fair, but it received positive reviews from most subjects. Given the observed usage and feedback, we suggest that mobile health-driven interventions consider including an activity tracker and bathroom scale. Furthermore, the data’s correlations with changes in patient-reported outcomes indicate the potential for these devices to be an effective way to remotely monitor heart failure patients.Competing Interest StatementG.C.F., reports consulting for Abbott, Amgen, Bayer, Janssen, Medtronic, and Novartis.Funding StatementThis work was supported by the National Institutes of Health and the National Heart, Lung, and Blood Institute under grant R56HL135425.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data collection and analysis presented in this work were carried out under research protocol #17-001312 approved by the University of California, Los Angeles, Institutional Review Board. We obtained signed informed consent from all participants in the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are not publicly available due to patient privacy restrictions but may be available from the corresponding author on reasonable request.